Expert Forum
CMC: A Developmental Approach to Ensure Drug Quality – from Small-Molecule Drugs to Biotherapeutics
Your registration was successful, and you can now watch and attend the on-demand presentation.
If you know a colleague who would benefit from this presentation, use the form to invite them.
After watching the presentation(s), please take a moment to share your extremely valuable insights. It will only take a few minutes.
CMC: A Solutions-Based Approach from Small-Molecule Drugs to Biotherapeutics
Presentation by Michael W. Dong, Ph.D.
An Overview of Key Differences of the CMC Process in Small-Molecule Drugs and Biotherapeutics
Presentation by Joseph L. Glajch, Ph.D.
Expert Forum Panel Discussion
Presenters / Panellists
Dr. Michael Dong
Principal Consultant
MWD Consulting (USA)
Dr. Michael W. Dong is a principal consultant at MWD Consulting, focusing on consulting and training services on HPLC, pharmaceutical analysis, and drug quality. He was formerly a Senior Scientist in Analytical Chemistry and Quality Control at Genentech, a Research Fellow at Purdue Pharma, a Senior Staff Scientist at Applied Biosystems/Perkin-Elmer, and a section head at Celanese Research Company. He holds a Ph.D. in Analytical Chemistry from the City University of New York. He has 130+ publications and five books, including a bestselling book on chromatography (HPLC and UHPLC for Practicing Scientists, 2nd Ed., Wiley, 2019). He is an advisory board member of LCGC magazine.
Dr. Joseph Glajch
Principal Consultant
JLG AP Consulting (USA)
Dr. Ewoud van Tricht
Principal Consultant & Co-Owner
Kantisto (The Netherlands)
Expert in (bio)pharmaceutical analysis with over 18 years of industrial experience in analytical development, Quality Control, and Analytical Quality by Design (AQbD). He has contributed to diverse therapeutic modalities, including small molecules, viruses, and cells, at leading companies such as Janssen Vaccines and Sanofi Cell Therapy.
Moderators
Prof. Dr. Cari Sänger-van de Griend
Expert in (bio)pharmaceutical analytical chemistry with 30 years of industrial and academic experience in method development and control strategies, including Analytical Quality by Design (AQbD), and focused on best practices and knowledge sharing.
Brought to you by:
Ask a Question
Join the conversation (or start a discussion) on the BioQC User Community.
Contact Us
If you have any questions about the event, don’t hesitate to get in touch with the BioQC Team: Feedback & General Enquiry